Phelophepa Train offers 2-week trip to Africa as prize in donation drive

Article

The American Friends of the Phelophepa Train are launching their first first-ever Eye Clinic Donation Drive to raise funds for the purchase of 50,000 pairs of eyeglasses to be dispensed at the eye clinic on board 18-car trains that travel throughout South Africa delivering primary healthcare services to under-served villagers.

 

New York-The American Friends of the Phelophepa Train (AFPT) are launching their first first-ever Eye Clinic Donation Drive to raise funds for the purchase of 50,000 pairs of eyeglasses to be dispensed at the eye clinic on board 18-car trains that travel throughout South Africa delivering primary healthcare services to under-served villagers.

The Donation Drive offers the opportunity to win a 14-day trip to South Africa for two people valued at $40,000, including a day on-board the Phelophepa Train. For every $5 donation, donors will be entered into a sweepstakes drawing to win this luxury trip.

The objective of this fundraising drive is to raise awareness that nearly two thirds of all blindness in rural Africa is avoidable through early detection, prevention, and management programs to reduce the impact of visual impairment. The goal of this campaign is to fund the purchase of 50,000 pairs of eyeglasses that the train dispenses each year and to raise money to support the cataract, refractive, and glaucoma treatment programs provided by Phelophepa.

The Phelophepa Train has served more than 14.5 million people and distributed more than 500,000 pairs of eyeglasses since it began operating in 1994. In a country where 80% of people have inadequate access to eyecare services and where more than 100 people go blind every day due to preventable causes, Phelophepa has become known as the Train of Hope.

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.